Viking Therapeutics (VKTX) and Carvana (CVNA) are experiencing unusually high options trading volume today, with VKTX options volume reaching 77.2% and CVNA options volume hitting 75.5% of their respective average daily share trading volumes. Notably, long-dated call options, specifically the November 2025 $40 strike for VKTX and the December 2025 $420 strike for CVNA, saw significant activity, suggesting increased speculative interest or hedging strategies anticipating future price movements in these equities.
Viking Therapeutics (VKTX) and Carvana (CVNA) are exhibiting notably elevated options trading volumes today, signaling significant market interest. VKTX options volume reached 77.2% of its average daily share trading volume, while CVNA's options volume hit 75.5% of its respective average. This substantial activity suggests a concentration of capital in derivative instruments for these names. Specifically, long-dated call options are attracting considerable attention. For VKTX, the November 2025 $40 strike call saw 4,034 contracts trade, and for CVNA, the December 2025 $420 strike call recorded 3,031 contracts. This focused activity in out-of-the-money, long-dated calls typically indicates either strong speculative conviction for future price appreciation or strategic hedging against existing positions. The disproportionately high options volume relative to underlying share trading volume, particularly in these specific call strikes, points to a potential inflection point or anticipated catalyst for both companies. While the article's sentiment analysis is neutral, the technical flow suggests institutional or sophisticated retail positioning that warrants close observation for potential future equity movements.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
